MP
Therapeutic Areas
Ilya Pharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| ILP100-Topical | Wound healing (e.g., in SAVI patients) | Phase 2/3 |
| ILP100-Oral | Colitis (e.g., ICI-induced) | Pre-clinical |
| ILP101-Inhale | Preserving lung function (e.g., in Cystic Fibrosis, SAVI) | Pre-clinical |